Daiichi Sankyo Company, Limited (DSKYF)
USD 26.5
(0.0%)
USD 26.5
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -259.26 Billion JPY | -284.22% |
| 2023 | -141.96 Billion JPY | 57.82% |
| 2022 | -336.56 Billion JPY | -390.4% |
| 2021 | -68.63 Billion JPY | -387.5% |
| 2020 | -14.07 Billion JPY | -113.15% |
| 2019 | 107.06 Billion JPY | 348.15% |
| 2018 | 23.89 Billion JPY | -33.81% |
| 2017 | 36.09 Billion JPY | 294.66% |
| 2016 | -18.54 Billion JPY | -157.85% |
| 2015 | 32.05 Billion JPY | -86.67% |
| 2014 | 240.54 Billion JPY | 217.89% |
| 2013 | 75.67 Billion JPY | 22.06% |
| 2012 | 61.99 Billion JPY | 65.94% |
| 2011 | 37.36 Billion JPY | -80.33% |
| 2010 | 189.91 Billion JPY | -24.25% |
| 2009 | 250.72 Billion JPY | 630.65% |
| 2008 | -47.24 Billion JPY | 70.93% |
| 2007 | -162.52 Billion JPY | 21.51% |
| 2006 | -207.05 Billion JPY | -32.82% |
| 2005 | -155.88 Billion JPY | -14.28% |
| 2004 | -136.41 Billion JPY | -9.22% |
| 2003 | -124.89 Billion JPY | 0.0% |
| 2002 | - JPY | 0.0% |
| 2001 | - JPY | 0.0% |
| 2000 | - JPY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -376.67 Billion JPY | -165.32% |
| 2024 FY | -259.26 Billion JPY | -82.62% |
| 2024 Q2 | -488.86 Billion JPY | -29.79% |
| 2024 Q4 | -259.26 Billion JPY | 54.11% |
| 2024 Q3 | -564.93 Billion JPY | -15.56% |
| 2023 Q1 | -494.69 Billion JPY | -46.99% |
| 2023 Q3 | -251.99 Billion JPY | 25.21% |
| 2023 FY | -141.96 Billion JPY | 57.82% |
| 2023 Q4 | -141.96 Billion JPY | 43.66% |
| 2023 Q2 | -336.94 Billion JPY | 31.89% |
| 2022 Q1 | -168.52 Billion JPY | 14.33% |
| 2022 Q2 | -386.4 Billion JPY | -129.29% |
| 2022 Q3 | -413.74 Billion JPY | -7.07% |
| 2022 FY | -336.56 Billion JPY | -390.4% |
| 2022 Q4 | -336.56 Billion JPY | 18.65% |
| 2021 Q3 | -336.15 Billion JPY | -25.78% |
| 2021 Q2 | -267.25 Billion JPY | -69.15% |
| 2021 Q4 | -196.71 Billion JPY | 41.48% |
| 2021 FY | -68.63 Billion JPY | -387.5% |
| 2021 Q1 | -157.99 Billion JPY | 21.0% |
| 2020 Q3 | -102.1 Billion JPY | -41.67% |
| 2020 Q1 | -36.42 Billion JPY | -304.88% |
| 2020 FY | -14.07 Billion JPY | -113.15% |
| 2020 Q4 | -199.98 Billion JPY | -95.85% |
| 2020 Q2 | -72.07 Billion JPY | -97.87% |
| 2019 Q3 | 21.41 Billion JPY | -9.74% |
| 2019 Q4 | 17.77 Billion JPY | -16.97% |
| 2019 FY | 107.06 Billion JPY | 348.15% |
| 2019 Q1 | -13.41 Billion JPY | 82.61% |
| 2019 Q2 | 23.72 Billion JPY | 276.85% |
| 2018 Q3 | -8.06 Billion JPY | 81.46% |
| 2018 FY | 23.89 Billion JPY | -33.81% |
| 2018 Q2 | -43.5 Billion JPY | -383.73% |
| 2018 Q4 | -77.13 Billion JPY | -856.45% |
| 2018 Q1 | 15.33 Billion JPY | -55.55% |
| 2017 Q3 | 83.78 Billion JPY | 270183.87% |
| 2017 Q1 | -57.88 Billion JPY | -173.58% |
| 2017 FY | 36.09 Billion JPY | 294.66% |
| 2017 Q4 | 34.49 Billion JPY | -58.83% |
| 2017 Q2 | 31 Million JPY | 100.05% |
| 2016 Q4 | -21.15 Billion JPY | 41.43% |
| 2016 Q2 | -14.35 Billion JPY | 17.59% |
| 2016 Q3 | -36.12 Billion JPY | -151.74% |
| 2016 FY | -18.54 Billion JPY | -157.85% |
| 2016 Q1 | -17.41 Billion JPY | -154.32% |
| 2015 Q1 | 193.03 Billion JPY | -19.75% |
| 2015 Q3 | 122.24 Billion JPY | -31.59% |
| 2015 Q4 | 32.05 Billion JPY | -73.78% |
| 2015 FY | 32.05 Billion JPY | -86.67% |
| 2015 Q2 | 178.69 Billion JPY | -7.43% |
| 2014 Q4 | 240.54 Billion JPY | 9.89% |
| 2014 Q3 | 218.89 Billion JPY | -15.03% |
| 2014 Q2 | 257.61 Billion JPY | 142.62% |
| 2014 Q1 | 106.18 Billion JPY | 40.32% |
| 2014 FY | 240.54 Billion JPY | 217.89% |
| 2013 Q4 | 75.67 Billion JPY | -30.59% |
| 2013 FY | 75.67 Billion JPY | 22.06% |
| 2013 Q3 | 109.02 Billion JPY | -11.96% |
| 2013 Q2 | 123.83 Billion JPY | -4.55% |
| 2013 Q1 | 129.73 Billion JPY | 109.27% |
| 2012 FY | 61.99 Billion JPY | 65.94% |
| 2012 Q1 | 175.83 Billion JPY | 370.64% |
| 2012 Q2 | 175.85 Billion JPY | 0.01% |
| 2012 Q3 | 170.04 Billion JPY | -3.31% |
| 2012 Q4 | 61.99 Billion JPY | -63.54% |
| 2011 Q4 | 37.36 Billion JPY | -71.02% |
| 2011 FY | 37.36 Billion JPY | -80.33% |
| 2011 Q1 | 128.14 Billion JPY | -32.53% |
| 2011 Q2 | 114.87 Billion JPY | -10.35% |
| 2011 Q3 | 128.93 Billion JPY | 12.24% |
| 2010 Q3 | 209.41 Billion JPY | -4.73% |
| 2010 FY | 189.91 Billion JPY | -24.25% |
| 2010 Q2 | 219.8 Billion JPY | 0.0% |
| 2010 Q4 | 189.91 Billion JPY | -9.31% |
| 2009 FY | 250.72 Billion JPY | 630.65% |
| 2009 Q4 | 250.72 Billion JPY | 0.0% |
| 2008 FY | -47.24 Billion JPY | 70.93% |
| 2007 FY | -162.52 Billion JPY | 21.51% |
| 2006 FY | -207.05 Billion JPY | -32.82% |
| 2005 FY | -155.88 Billion JPY | -14.28% |
| 2004 FY | -136.41 Billion JPY | -9.22% |
| 2003 FY | -124.89 Billion JPY | 0.0% |
| 2002 FY | - JPY | 0.0% |
| 2001 FY | - JPY | 0.0% |
| 2000 FY | - JPY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AstraZeneca PLC | 22.74 Billion USD | 1239.622% |
| Bristol-Myers Squibb Company PFD CONV 2 | 30 Billion USD | 964.207% |
| CSPC Pharmaceutical Group Limited | -1.59 Billion USD | -16164.456% |
| Clarus Therapeutics Holdings, Inc. | 15.85 Million USD | 1635409.701% |
| Novartis AG | 12.95 Billion USD | 2101.25% |
| PT Kalbe Farma Tbk. | -169.7 Million USD | -152675.248% |